Kazuwa Nakao

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Shionogi Company Limited, Chugai Seiyaku Kabushiki Kaisha, Shionogi Sieyaku Kabushiki Kaisha. Active years: 1987-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuwa Nakao. Retrieved from https://idiyas.com/inventor/kazuwa-nakao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 1)

% Patents Active = 83.3

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 110(Granted Patents)

Location History:

Kyoto-shi, Kyoto, JP (2004 - 2010)
Kyoto, JP (1987 - 2014)

Company Filing History:

3 out of 1,001

Shionogi Company Limited

patents

2 out of 987

Chugai Seiyaku Kabushiki Kaisha

patents

2 out of 2

Shionogi Sieyaku Kabushiki Kaisha

Mitsubishi Tanabe Pharma Corporation

patents

7. 1 out of 25

Shionogi Seiyaku Kabushiki Kaisha

patents

8. 3 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1987-2014

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8815803 - Method for increasing body height comprising systemic administration of CNP-53 (2014-08-26),

2. 8658373 - Method of screening for an agent for treating arthritis and promoting growth of articular chondrocytes (2014-02-25),

3. 7642243 - Method of treating arthritis and promoting growth of articular chondrocytes (2010-01-05),

4. 7572630 - Method for differentiating primate embryonic stem cell into vascular cell (2009-08-11),

5. 7452970 - Human endothelin receptor (2008-11-18),

6. 6822078 - Diagnostic drugs for autoimmune diseases (2004-11-23),

7. 6821743 - Human endothelin receptor (2004-11-23),

8. 6743425 - Therapeutic agents for achondroplasia (2004-06-01),

9. 6313276 - Human endothelin receptor (2001-11-06),

10. 5124264 - Monoclonal antibody recognizing atrial natriuretic polypeptide (1992-06-23),

11. 5124248 - Monoclonal antibody recognizing gamma atrial natriuretic polypeptide (1992-06-23),

12. 4673732 - Polypeptide relating to .alpha.-hANP (1987-06-16),

Title: Kazuwa Nakao: Innovator in Growth and Arthritis Treatments

Introduction

Kazuwa Nakao is a prominent inventor based in Kyoto, Japan, known for his significant contributions to medical science. With a total of 12 patents, Nakao has focused on innovative methods to enhance body height and treat arthritis.

Latest Patents

One of Nakao's latest patents is a method for increasing body height through the systemic administration of CNP-53. This invention offers a composition aimed at increasing the height of individuals with short stature, specifically targeting those without FGFR3 abnormalities. The composition includes a guanyl cyclase B (GC-B) activator as its active ingredient. Additionally, Nakao has developed a method for screening agents that promote body height by utilizing GC-B activity as an indicator. Another notable patent involves a method for screening agents to treat arthritis and promote the growth of articular chondrocytes. This invention provides a new therapeutic agent for conditions like osteoarthritis, also utilizing a GC-B activator.

Career Highlights

Throughout his career, Nakao has worked with various companies, including Shionogi & Company Limited. His innovative work has led to advancements in treatments that significantly impact patients' quality of life.

Collaborations

Nakao has collaborated with notable colleagues such as Hiroo Imura and Hidetomo Kitamura, contributing to the development of groundbreaking medical solutions.

Conclusion

Kazuwa Nakao's work exemplifies the intersection of innovation and healthcare, with his patents paving the way for new treatments in growth enhancement and arthritis management. His contributions continue to influence the medical field positively.

Profile summary based on public USPTO records.